Lymphocyte Activation Gene-3 Blocker class drugs
1 result
Opdualag (nivolumab and relatlimab-rmbw)
(nivolumab and relatlimab-rmbw)E.R. Squibb & Sons, L.L.C.
Usage: OPDUALAG™ is indicated for treating adult and pediatric patients aged 12 and older with unresectable or metastatic melanoma.